Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis — StellaPhase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(3 sites)
United States
Vanderbilt Ingram Cancer Center, Nashville, Tennessee UT Southwestern Medical Center, Dallas, Texas Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah Age range
18 Years and older
Last updated February 2026